Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02570308
Recruitment Status : Active, not recruiting
First Posted : October 7, 2015
Last Update Posted : July 31, 2019
Sponsor:
Information provided by (Responsible Party):
Immunocore Ltd

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2020
Study Completion Date : No date given